EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Strategy for the Optimization of Read-Through Therapy for Junctional Epidermolysis Bullosa with COL17A1 Nonsense Mutation

Saliha Beyza Sayar, Cristina Has

Journal of Investigative Dermatology · 2024

DOI: 10.1016/j.jid.2024.02.027 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Investigative Dermatology, 2024. Verfasst von Saliha Beyza Sayar und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Medical Center, University of Freiburg, Freiburg, Germany. Electronic address: saliha.beyza.sayar@uniklinik-freiburg.de. Hauptthemen laut MEDLINE: Codon, Nonsense, Epidermolysis Bullosa, Junctional, Collagen Type XVII, Non-Fibrillar Collagens. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Read-through therapy suppresses premature termination codons and induces read-through activity, consequently restoring missing proteins. Aminoglycosides are widely studied as read-through drugs in different human genetic disorders, including hereditary skin diseases. Our previous work revealed that aminoglycosides affect COL17A1 nonsense mutations and represent a therapeutic option to alleviate disease severity. However, the amount of restored type XVII collagen (C17) in C17-deficient junctional epidermolysis bullosa keratinocytes was

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Codon, NonsenseEpidermolysis Bullosa, JunctionalCollagen Type XVIINon-Fibrillar CollagensKeratinocytesAutoantigensHumansCells, Cultured

Stichwörter der Autor:innen

Collagen XVIIEpidermolysis bullosaGenodermatosisNonsense mutationTranslational read-through–inducing drugs

Substanzen

Codon, NonsenseCollagen Type XVIINon-Fibrillar CollagensAutoantigens

Autor:innen und Institutionen

  • Department of Dermatology, Medical Center, University of Freiburg, Freiburg, Germany. Electronic address: saliha.beyza.sayar@uniklinik-freiburg.de.
  • Department of Dermatology, Medical Center, University of Freiburg, Freiburg, Germany. Electronic address: cristina.has@uniklinik-freiburg.de.

Zitieren

APA

Sayar, S. B., & Has, C. (2024). Strategy for the Optimization of Read-Through Therapy for Junctional Epidermolysis Bullosa with COL17A1 Nonsense Mutation. Journal of Investigative Dermatology. https://doi.org/10.1016/j.jid.2024.02.027

Vancouver

Sayar SB, Has C. Strategy for the Optimization of Read-Through Therapy for Junctional Epidermolysis Bullosa with COL17A1 Nonsense Mutation. Journal of Investigative Dermatology. 2024. doi:10.1016/j.jid.2024.02.027

BibTeX
@article{Sayar2024,
  author = {Sayar, Saliha Beyza and Has, Cristina},
  title = {Strategy for the Optimization of Read-Through Therapy for Junctional Epidermolysis Bullosa with COL17A1 Nonsense Mutation},
  journal = {Journal of Investigative Dermatology},
  year = {2024},
  doi = {10.1016/j.jid.2024.02.027}
}
Kostenlos starten →